Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction.

REASONS FOR PERFORMING STUDY: Although the efficacy of dexamethasone for the treatment of recurrent airway obstruction (RAO) has been documented, the speed of onset of effect and duration of action are unknown, as is the efficacy of orally administered dexamethasone with or without fasting. OBJECTIVES: To document the time of onset of effect and duration of action of a dexamethasone solution i.v. or orally with and without fasting. METHODS: Protocol 1 used 8 RAO-affected horses with airway obstruction in a crossover design experiment that compared the effect of i.v. saline and dexamethasone (0.1 mg/kg bwt) on pulmonary function over 4 h. Protocol 2 used 6 similar horses to compare, in a crossover design, the effects of dexamethasone i.v. (0.1 mg/kg bwt), dexamethasone per os (0.164 mg/kg bwt) with and without prior fasting, and dexamethasone per os (0.082 mg/kg) with fasting. RESULTS: Dexamethasone i.v. caused significant improvement in lung function within 2 h with a peak effect at 4-6 h. Dexamethasone per os was effective within 6 h with peak effect at 24 h at a dose of 0.164 mg/kg bwt prior to feeding. The duration of effect was, for all dexamethasone treatments, statistically significant for 30 h when compared to saline and tended to have a longer duration of effect when used orally. Dexamethasone per os at a dose of 0.164 mg/kg bwt to fed horses had mean effects comparable to dexamethasone at a dose of 0.082 mg/kg bwt per os given to fasted horses, indicating that feeding decreases bioavailability. CONCLUSIONS: Dexamethasone administered i.v. has a rapid onset of action in RAO-affected horses. Oral administration of a bioequivalent dose of the same solution to fasted horses is as effective as i.v. administration and tends to have longer duration of action. Fasting horses before oral administration of dexamethasone improves the efficacy of treatment. POTENTIAL RELEVANCE: Oral administration to fasted horses of a dexamethasone solution intended for i.v. use provides an effective treatment for RAO-affected animals.

Drinking salt water enhances rehydration in horses dehydrated by frusemide administration and endurance exercise.

Because the primary stimulus for thirst is an increase in plasma tonicity, we hypothesised that dehydrated horses would drink a greater total volume of fluid voluntarily during the first hour of recovery when they were initially offered salt water. To test this hypothesis, bodyweight (bwt), fluid intake (FI) and [Na+] were measured in 6 Arabian horses offered 3 rehydration solutions. After dehydration was induced by frusemide administration (1 mg/kg bwt, i.v.) followed by 45 km treadmill exercise, water (W), 0.45% NaCl and 0.9% NaCl were offered, in a randomised order, during the initial 5 min after completing exercise. Horses were subsequently placed in a stall and further intake of plain water during the first hour of recovery was measured. By the end of exercise, horses lost 5.2 +/- 0.2, 5.6 +/- 0.3 and 5.7 +/- 0.2% (P>0.05) bwt and FI during the first 5 min of recovery was 10.5 +/- 0.7, 11.6 +/- 0.8 and 11.6 +/- 1.5 l (P>0.05) for W, 0.45% NaCl and 0.9% NaCl, respectively. After 20 min of recovery, [Na+] had decreased with W but remained unchanged from the end exercise values for both saline solutions. During the initial hour of recovery, further water intake was 0.9 +/- 0.4, 5.0 +/- 0.5 and 6.9 +/- 0.7 l (P<0.05) for W, 0.45% NaCl and 0.9% NaCl, respectively. Therefore, total FI was 11.4 +/- 0.5, 16.6 +/- 0.7 and 18.5 +/- 1.7 l (P<0.05) for W, 0.45% NaCl and 0.9% NaCl, respectively, and persisting bwt loss after 60 min of recovery was greater (P<0.05) for W (3.5%) than for the 2 saline solutions (24% for 0.45% NaCl and 1.9% for 0.9% NaCl). In conclusion, providing salt water as the initial rehydration fluid maintained an elevated [Na+] and resulted in greater total FI and recovery of bwt loss during the first hour of recovery, in comparison to offering only plain water.